DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2021
    • New Researcher Network
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2020
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
  • About
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • External Events
    • 2021 ISAM Congress
    • RDD 2021
  • Contact
  • The Aerosol Society logo
loading...

Jim Clay :

Jim Clay

Senior Analytical Scientist, Kindeva Drug Delivery

Paper: Increased Sustainability Via the Use of Abbreviated Impactor Measurements (AIM) for Aerodynamic Particle Size Distribution (APSD) of Oral Pressurised Metered Dose Inhalers (pMDIs)

Download Paper

Jim is a Senior Analytical Scientist at Kindeva Drug Delivery in the UK.
After graduating with a degree in Applied Science and Forensic Measurement in 1998, Jim started his career in the pharmaceutical industry joining 3M Health Care Ltd, now Kindeva Drug Delivery, in 1999.
Throughout his career within the Inhalation Division, working predominantly within Analytical Research & Development, Jim has acquired extensive practical and theoretical knowledge of a large range of analytical techniques required for early phase and late stage development of Pressurized Metered Dose Inhalers (pMDIs) and Dry Powder Inhalers (DPIs).
Jim has enhanced his knowledge and expertise of OINDP whilst working on numerous feasibility studies and development programs.

Video of Jim Clay

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2021 Drug Delivery to the Lungs Website design: definingdesign.co.uk